GlassScriptPhysician profile
Paul T Ellis
NPI 1356317325
$5,774.03
in general payments reported to CMS, 2019-2025
43 companies · $727 in 2025
The $727 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $870 · 2021: $1,350 · 2022: $902 · 2023: $923 · 2024: $702 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,351.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,305.59 | 2020-2025 | Speedicath |
| Astellas Pharma US INC | $663.26 | 2019-2025 | Myrbetriq, Xtandi |
| Abbvie INC. | $554.70 | 2019-2025 | |
| Antares Pharma, INC. | $505.42 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Janssen Biotech, INC. | $476.82 | 2019-2025 | Erleada, Akeega |
| Merck Sharp & Dohme LLC | $234.03 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Urogen Pharma, INC. | $166.20 | 2022-2025 | Jelmyto |
| Tolmar Pharmaceuticals, INC. | $165.41 | 2020-2021 | |
| Boston Scientific Corporation | $161.40 | 2022-2025 | Ams 700, Watchman Flx, Solyx Sis System |
| Procept Biorobotics Corporation | $132.98 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Novartis Pharmaceuticals Corporation | $110.36 | 2022-2025 | |
| Pfizer INC. | $99.45 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $95.03 | 2021-2025 | Provenge |
| Olympus America INC. | $80.36 | 2022-2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $71.28 | 2021-2023 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $70.58 | 2022-2025 | Goby |
| Uronova Pharmaceuticals, INC. | $67.79 | 2025 | Vabrinty |
| Tolmar, INC. | $66.44 | 2023-2025 | Eligard, Jatenzo |
| Smith+Nephew, INC. | $65.44 | 2020-2023 | Stravix |
| Ferring Pharmaceuticals INC. | $58.68 | 2024-2025 | Adstiladrin |
| Convatec INC. | $58.07 | 2021-2022 | |
| Halozyme INC | $52.09 | 2023 | |
| Blue Earth Diagnostics | $49.78 | 2019-2024 | |
| Clarus Therapeutics INC. | $49.58 | 2021 | |
| Urovant Sciences INC | $47.68 | 2022 | |
| Myovant Sciences INC. | $42.29 | 2021 | |
| Endo USA, INC. | $34.40 | 2024-2025 | Xiaflex, Aveed |
| Travere Therapeutics, INC. | $26.36 | 2019 | |
| Axonics, INC. | $24.02 | 2024 | Axonics, Bulkamid |
| Astrazeneca Pharmaceuticals LP | $23.18 | 2022 | |
| Progenics Pharmaceuticals, INC. | $21.44 | 2024 | |
| Biotissue Holdings INC. | $21.23 | 2023 | |
| Medtronic, INC. | $19.71 | 2025 | Interstim |
| Baxter Healthcare | $18.98 | 2022 | |
| 180 Medical, INC. | $17.82 | 2024 | Gentlecath Glide |
| Calyxo, INC. | $17.74 | 2024 | Cvac Aspiration System |
| Genzyme Corporation | $17.55 | 2022 | |
| Teleflex LLC | $16.67 | 2023 | Urolift |
| Metuchen Pharmaceuticals | $16.18 | 2020 | |
| Angiodynamics, INC. | $13.95 | 2025 | Nanoknife |
| Baudax Bio INC. | $12.74 | 2020 | |
| Acerus Pharmaceuticals Corporation | $11.92 | 2020 | |
| Ambu INC. | $9.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.